Home › Sezary Syndrome › Pennsylvania › Philadelphia
Sezary Syndrome clinical trials in Philadelphia, PA
3 studies for Sezary Syndrome are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab
RecruitingObservational study
- Thomas Jefferson University Hospital, Philadelphia
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
RecruitingPhase 1
- University of Pennsylvania - Abramson Cancer Center, Philadelphia
A Registry for People With T-cell Lymphoma
RecruitingObservational study
- University of Pennsylvania (Data Collection Only), Philadelphia
- Thomas Jefferson University Hospital (Data collection only), Philadelphia
Sezary Syndrome trials in other cities
- Baldwin Park, CA7 studies
- Mountain View, CA5 studies
- Atlanta, GA4 studies
- New York City, NY4 studies
- Boston, MA4 studies
- Houston, TX4 studies
- Pittsburgh, PA3 studies
- St. Louis, MO3 studies
- Tampa, FL3 studies
Other studies in Philadelphia
- Cancer (all types)60 studies
- Breast Cancer56 studies
- Non-Small Cell Lung Cancer51 studies
- Metastatic Cancer46 studies
- Colorectal Cancer44 studies
- Ovarian Cancer44 studies
- Prostate Cancer44 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Heart Failure31 studies
- Endometrial Cancer29 studies
- Pancreatic Cancer26 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.